(Q39020651)

English

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden

scientific article published on 8 April 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Navaneethan Palanisamy

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Ida Lindström

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Midori Kjellin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Lars Wesslén

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Anders Lannergard

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Johan Lennerstrand

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

8 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

555-562

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Directly acting antivirals against hepatitis C virus

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Epidemiology of hepatitis B and C viruses: a global overview

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

HCV direct-acting antiviral agents: the best interferon-free combinations

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Update on hepatitis C virus resistance to direct-acting antiviral agents

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

In vitro activity of daclatasvir on hepatitis C virus genotype 3 NS5A.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Resistance to direct antiviral agents in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Prevalence of baseline polymorphisms for potential resistance to NS5A inhibitors in drug-naive individuals infected with hepatitis C genotypes 1-4.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

The role of resistance in HCV treatment

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1028097

21 January 2018

Identifiers

10.3109/23744235.2015.1028097

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851241%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39020651&oldid=2197035913"